Clinical Trials

A Phase 2, Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard dose and a High-dose Regimen in Patients With BRAFV600-Mutant Melanoma Brain Metastasis


Study ID
ARRAY-818-201

NCT Number
NCT03911869 (Click on the NCT number for more information about the trial)

Research Study Number
2019-0343

Principle Investigator
Dr. Pecora, Andrew

Phase
II

Sponsor
Array Biopharma, Inc.


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now